The present application relates to novel substituted benzimidazoles, to processes for their preparation, to their use, alone or in combinations, for the treatment and/or prophylaxis of diseases, and to their use for preparation of medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of endometriosis and endometriosis-associated pain and other endometriosis-associated symptoms such as dysmenorrhoea, dyspareunia, dysuria and dyschezia, of lymphoma, rheumatoid arthritis, spondyloarthritis (especially psoriatic spondyloarthritis and Bekhterev's disease), lupus erythematosus, multiple sclerosis, macular degeneration, COPD, gout, fatty liver disorders, insulin resistance, kidney disorders, neoplastic disorders and psoriasis.本發明關於新穎經取代之苯并咪唑,其製備方法,其單獨或以組合於治療及/或預防疾病之用途及其於製備用於治療及/或預防疾病之藥劑之用途,特定言之用於治療及/或預防子宮內膜異位症及與子宮內膜異位症相關聯之疼痛及諸如痛經、性交困難、排尿困難及排便困難之其他與子宮內膜異位症相關聯之症狀、淋巴瘤、類風濕性關節炎、脊柱關節炎(尤其牛皮癬性脊柱關節炎及別赫捷列夫氏病(Bekhterev's disease))、紅斑狼瘡、多發性硬化、黃斑變性、COPD、痛風、脂肪肝病、胰島素抗性、腎病、腫瘤性疾病及牛皮癬。